Kepler upgrades GSK to “buy,” raises target 68% on long-term outlook

Investing.com Gold reports: Kepler upgrades GSK to “buy,” raises target 68% on long-term outlook. Full body text was unavailable at ingest time, so this brief is based on headline context.